This is a Moderna news story, published by CNBC, that relates primarily to Moderna news.
For more Moderna news, you can click here:
more Moderna newsFor more Moderna news, you can click here:
more Moderna newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from CNBC, you can click here:
more news from CNBCOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Moderna. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest vaccination rates news, Covid vaccine news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Covid marketCNBC
•Health
Health
84% Informative
Moderna lowered its 2025 sales guidance by roughly $1 billion , as it continues to cut costs.
The biotech company now expects 2025 revenue to come in between $1.5 billion and $2.5 million .
The announcement comes as Moderna charts a path forward after the rapid decline in demand for its Covid vaccine.
VR Score
90
Informative language
91
Neutral language
74
Article tone
informal
Language
English
Language complexity
40
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
1
Source diversity
1
Affiliate links
no affiliate links
